BRIEF-Revive Therapeutics Advances Research Program Of Cannabinoid-Based Therapies Targeting Liver Diseases

1 Min Read

Jan 30 (Reuters) - Revive Therapeutics Ltd:

* REVIVE THERAPEUTICS ADVANCES RESEARCH PROGRAM OF CANNABINOID-BASED THERAPIES TARGETING LIVER DISEASES

* REVIVE THERAPEUTICS LTD - RESEARCH WILL BE OVERSEEN BY SANYAL BIOTECHNOLOGY LLC COMPANY’S STRATEGIC RESEARCH PARTNER FOR LIVER DISEASES Source text for Eikon: Further company coverage:

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below